Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

XPO1

Introduction

Exportin 1 (XPO1), also known as chromosomal maintenance 1 (CRM1), is an eukaryotic protein that mediates the nuclear export of proteins, rRNA, snRNA, and some mRNA.[1][2][3][4]

History

History

XPO1 (CRM1) originally was identified in the fission yeast Schizosaccharomyces pombe in a genetic screen, and investigators determined that it was involved in control of the chromosome structure[5]

Function

Function

Exportin 1 mediates leucine-rich nuclear export signal (NES)-dependent protein transport. Exportin 1 specifically mediates the nuclear export of Rev and U snRNAs. It is involved in the control of several cellular processes by controlling the localization of cyclin B, MAPK, and MAPKAP kinase 2. This protein also regulates NFAT and AP-1.[6]

Interactions

Interactions

XPO1 has been shown to interact with:

See also

See also

References

References

  1. ↑ Fornerod M, Ohno M, Yoshida M, Mattaj IW (September 1997). “CRM1 is an export receptor for leucine-rich nuclear export signals”. Cell. 90 (6): 1051–60. doi:10.1016/S0092-8674(00)80371-2. PMIDΒ 9323133.
  2. ↑ Kudo N, Khochbin S, Nishi K, Kitano K, Yanagida M, Yoshida M, Horinouchi S (Dec 1997). “Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins”. J Biol Chem. 272 (47): 29742–51. doi:10.1074/jbc.272.47.29742. PMIDΒ 9368044.
  3. ↑ KΓΆhler, Alwin; Hurt, Ed (October 2007). “Exporting RNA from the nucleus to the cytoplasm”. Nature Reviews Molecular Cell Biology. 8 (10): 761–773. doi:10.1038/nrm2255. PMIDΒ 17786152.
  4. ↑ Lu C, Figueroa JA, Liu Z, Konala V, Aulakh A, Verma R, Cobos E, Chiriva-Internati M, Gao W (September 2015). “Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection”. Current Cancer Drug Targets. 15 (7): 575–592. doi:10.2174/156800961507150828223554.
  5. ↑ Noske A, Weichert W, Niesporek S, RΓΆske A, Buckendahl AC, Koch I, Sehouli J, Dietel M, Denkert C (Apr 2008). “Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer”. Cancer. 112 (8): 1733–43. doi:10.1002/cncr.23354. PMIDΒ 18306389.
  6. ↑ “Entrez Gene: XPO1 exportin 1 (CRM1 homolog, yeast)”.
  7. ↑ 7.0 7.1 Tickenbrock L, Cramer J, Vetter IR, Muller O (August 2002). “The coiled coil region (amino acids 129-250) of the tumor suppressor protein adenomatous polyposis coli (APC). Its structure and its interaction with chromosome maintenance region 1 (Crm-1)”. J. Biol. Chem. 277 (35): 32332–8. doi:10.1074/jbc.M203990200. PMIDΒ 12070164.
  8. ↑ Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI (April 2002). “Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export”. J. Biol. Chem. 277 (17): 14355–8. doi:10.1074/jbc.C100762200. PMIDΒ 11889117.
  9. ↑ Connor MK, Kotchetkov R, Cariou S, Resch A, Lupetti R, Beniston RG, Melchior F, Hengst L, Slingerland JM (January 2003). “CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis”. Mol. Biol. Cell. 14 (1): 201–13. doi:10.1091/mbc.E02-06-0319. PMCΒ 140238. PMIDΒ 12529437.
  10. ↑ Raval A, Weissman JD, Howcroft TK, Singer DS (January 2003). “The GTP-binding domain of class II transactivator regulates its nuclear export”. J. Immunol. 170 (2): 922–30. doi:10.4049/jimmunol.170.2.922. PMIDΒ 12517958.
  11. ↑ Voong LN, Slater AR, Kratovac S, Cressman DE (April 2008). “Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator”. J. Biol. Chem. 283 (14): 9031–9. doi:10.1074/jbc.M706487200. PMCΒ 2431044. PMIDΒ 18245089.
  12. ↑ Thomas F, Kutay U (June 2003). “Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway”. J. Cell Sci. 116 (Pt 12): 2409–19. doi:10.1242/jcs.00464. PMIDΒ 12724356.
  13. ↑ 13.0 13.1 Lindsay ME, Holaska JM, Welch K, Paschal BM, Macara IG (June 2001). “Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export”. J. Cell Biol. 153 (7): 1391–402. doi:10.1083/jcb.153.7.1391. PMCΒ 2150735. PMIDΒ 11425870.
  14. ↑ Kehlenbach RH, Dickmanns A, Kehlenbach A, Guan T, Gerace L (May 1999). “A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export”. J. Cell Biol. 145 (4): 645–57. doi:10.1083/jcb.145.4.645. PMCΒ 2133185. PMIDΒ 10330396.
  15. ↑ 15.0 15.1 Plafker K, Macara IG (May 2000). “Facilitated nucleocytoplasmic shuttling of the Ran binding protein RanBP1”. Mol. Cell. Biol. 20 (10): 3510–21. doi:10.1128/mcb.20.10.3510-3521.2000. PMCΒ 85643. PMIDΒ 10779340.
  16. ↑ Singh BB, Patel HH, Roepman R, Schick D, Ferreira PA (Dec 1999). “The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1”. J. Biol. Chem. 274 (52): 37370–8. doi:10.1074/jbc.274.52.37370. PMIDΒ 10601307.
  17. ↑ Lindsay ME, Plafker K, Smith AE, Clurman BE, Macara IG (August 2002). “Npap60/Nup50 is a tri-stable switch that stimulates importin-alpha:beta-mediated nuclear protein import”. Cell. 110 (3): 349–60. doi:10.1016/s0092-8674(02)00836-x. PMIDΒ 12176322.
  18. ↑ Fornerod M, Ohno M, Yoshida M, Mattaj IW (September 1997). “CRM1 is an export receptor for leucine-rich nuclear export signals”. Cell. 90 (6): 1051–60. doi:10.1016/s0092-8674(00)80371-2. PMIDΒ 9323133.
  19. ↑ Craig E, Zhang ZK, Davies KP, Kalpana GV (January 2002). “A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis”. EMBO J. 21 (1–2): 31–42. doi:10.1093/emboj/21.1.31. PMCΒ 125819. PMIDΒ 11782423.
  20. ↑ Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M, Fukasawa K (September 2007). “Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation”. Nat. Cell Biol. 9 (10): 1175–83. doi:10.1038/ncb1638. PMIDΒ 17891139.
  21. ↑ Shao C, Lu C, Chen L, Koty PP, Cobos E, Gao W (August 2010). “p53-Dependent anticancer effects of leptomycin B on lung adenocarcinoma”. Cancer Chemother. Pharmacol. 67 (6): 1369–80. doi:10.1007/s00280-010-1434-6. PMIDΒ 20803015.
Further reading

Further reading

External links